Company Sangui Biotech International, Inc. OTC Markets
Equities
SGBI
US80105B1017
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0015 USD | +25.00% |
|
-.--% | -48.28% |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Thomas Striepe
CEO | Chief Executive Officer | 62 | 06/02/05 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Thomas Striepe
CEO | Chief Executive Officer | 62 | 06/02/05 |
Hubertus Schmelz
BRD | Director/Board Member | 68 | 17/12/08 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 209,955,598 | 182,538,524 ( 86.94 %) | 53,756 ( 0.0256 %) | 86.94 % |
Company contact information
Sangui BioTech International, Inc.
Bleichenbruecke 9
20354, Hamburg
+49 40 609 3120
http://www.sanguibiotech.com![address Sangui Biotech International, Inc.(SGBI)](https://cdn.zonebourse.com/static/address/120787494.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+19.41% | 45.51B | |
+38.65% | 38.13B | |
-8.62% | 38.52B | |
+26.95% | 30.74B | |
-13.50% | 26.03B | |
+10.74% | 25.92B | |
+44.87% | 14.13B | |
+34.36% | 12.73B | |
-7.14% | 11.29B |
- Stock Market
- Equities
- SBH Stock
- SGBI Stock
- Company Sangui Biotech International, Inc.